ArticleHemaSphere2026

From monoclonal to polyfunctional immunotherapy: Reprogramming CAR-T-cell therapy with oncolytic viruses in B-cell malignancies.

Eduard Achim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.